M Marano1,2, F Rossi3, L Ravà4, M Khalil Ramla5, M Pisani6, G Bottari7, L Genuini7, G Zampini7, J Nunziata7, A Reale6, M A Barbieri3, F Celeani8, M Di Nardo7, C Cecchetti7, F Stoppa7, A Villani6, M Raponi9, S Livadiotti10, G Pontrelli10. 1. DEA Paediatric Intensive Care Unit, Children's Hospital Bambino Gesù, IRCCS, Rome, Italy. marco.marano@opbg.net. 2. Paediatric Clinical Toxicology Centre, Children's Hospital Bambino Gesù, IRCCS, Rome, Italy. marco.marano@opbg.net. 3. Emergency Department, Children's Hospital Bambino Gesù, IRCCS, Palidoro, Italy. 4. Epidemiology Unit and Biostatistics, Children's Hospital Bambino Gesù, IRCCS, Rome, Italy. 5. Paediatric Clinical Toxicology Centre, Children's Hospital Bambino Gesù, IRCCS, Rome, Italy. 6. Emergency Department, Children's Hospital Bambino Gesù, IRCCS, Rome, Italy. 7. DEA Paediatric Intensive Care Unit, Children's Hospital Bambino Gesù, IRCCS, Rome, Italy. 8. Information Systems Department, General direction Children's Hospital Bambino Gesù, IRCCS, Rome, Italy. 9. Medical Direction, Children's Hospital Bambino Gesù, IRCCS, Rome, Italy. 10. Clinical Trials Centre, University Department of Paediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Abstract
INTRODUCTION: Acute pediatric poisoning is an emerging health and social problem. The aim of this study is to describe the characteristics of a large pediatric cohort exposed to xenobiotics, through the analysis of a Pediatric Poison Control Center (PPCc) registry. METHODS: This study, conducted in the Pediatric Hospital Bambino Gesù of Rome, a reference National Pediatric Hospital, collected data of children whose parents or caregivers contacted the PPCc by phone (group "P"), or who presented to the Emergency Department (group "ED"), during the three-year period 2014-2016. Data were prospectively and systematically collected in a pre-set electronic registry. Comparisons among age groups were performed and multivariable logistic regression models used to investigate associations with outcomes (hospital referral for "P", and hospital admission for "ED"group). RESULTS: We collected data of 1611 children on group P and 1075 on group ED. Both groups were exposed to both pharmaceutical and non-pharmaceutical agents. Pharmaceutical agent exposure increased with age and the most common route of exposure was oral. Only 10% among P group were symptomatic children, with gastrointestinal symptoms. Among the ED patients, 30% were symptomatic children mostly with gastrointestinal (55.4%) and neurologic symptoms (23.8%). Intentional exposure (abuse substance and suicide attempt), which involved 7.7% of patients, was associated with older age and Hospital admission. CONCLUSIONS: Our study describes the characteristics of xenobiotics exposures in different paediatric age groups, highlighting the impact of both pharmacological and intentional exposure. Furthermore, our study shows the utility of a specific PPCc, either through Phone support or by direct access to ED. PPCc phone counselling could avoid unnecessary access to the ED, a relevant achievement, particularly in the time of a pandemic.
INTRODUCTION: Acute pediatric poisoning is an emerging health and social problem. The aim of this study is to describe the characteristics of a large pediatric cohort exposed to xenobiotics, through the analysis of a Pediatric Poison Control Center (PPCc) registry. METHODS: This study, conducted in the Pediatric Hospital Bambino Gesù of Rome, a reference National Pediatric Hospital, collected data of children whose parents or caregivers contacted the PPCc by phone (group "P"), or who presented to the Emergency Department (group "ED"), during the three-year period 2014-2016. Data were prospectively and systematically collected in a pre-set electronic registry. Comparisons among age groups were performed and multivariable logistic regression models used to investigate associations with outcomes (hospital referral for "P", and hospital admission for "ED"group). RESULTS: We collected data of 1611 children on group P and 1075 on group ED. Both groups were exposed to both pharmaceutical and non-pharmaceutical agents. Pharmaceutical agent exposure increased with age and the most common route of exposure was oral. Only 10% among P group were symptomatic children, with gastrointestinal symptoms. Among the ED patients, 30% were symptomatic children mostly with gastrointestinal (55.4%) and neurologic symptoms (23.8%). Intentional exposure (abuse substance and suicide attempt), which involved 7.7% of patients, was associated with older age and Hospital admission. CONCLUSIONS: Our study describes the characteristics of xenobiotics exposures in different paediatric age groups, highlighting the impact of both pharmacological and intentional exposure. Furthermore, our study shows the utility of a specific PPCc, either through Phone support or by direct access to ED. PPCc phone counselling could avoid unnecessary access to the ED, a relevant achievement, particularly in the time of a pandemic.
Entities:
Keywords:
Childhood; Emergency department; Intoxication; Paediatric poisoning; Pharmaceuticals; Poison control Centre